CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Data driven model discovery and interpretation for CAR T-cell killing using sparse identification and latent variables.
Data driven model discovery and interpretation for CAR T-cell killing using sparse identification and latent variables.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
在基于细胞的癌症疗法开发中,细胞相互作用的定量数学模型对于理解治疗效果至关重要。验证和解释癌细胞生长与死亡的数学模型,首先需要提出一个精确的数学模型,然后在所选模型的框架下分析实验数据。在这项工作中,我们首次将非线性动力学稀疏辨识(SINDy)算法应用于真实生物系统,以从体外实验数据中发现细胞-细胞相互作用动力学,使用的是嵌合抗原受体(CAR)T细胞和患者来源的胶质母细胞瘤细胞。通过结合潜变量分析和SINDy技术,我们推断了CAR-T 细胞群体与癌症相互作用动力学的关键方面。
重要的是,我们展示了模型项如何在生物学上与不同的CAR-T 细胞功能反应、单或双CAR-T 细胞-癌细胞结合模型,以及CAR-T 细胞或癌细胞群体中的密度依赖性生长动力学相关联。
我们展示了与已建立的模型优先方法相比,这种基于数据驱动的模型发现方法如何为CAR-T 细胞动力学提供独特见解。这些结果证明了SINDy通过增进对CAR-T 细胞动力学的理解,在临床上改善CAR-T 细胞疗法的实施和疗效的潜力。
In the development of cell-based cancer therapies, quantitative mathematical models of cellular interactions are instrumental in understanding treatment efficacy. Efforts to validate and interpret mathematical models of cancer cell growth and death hinge first on proposing a precise mathematical model, then analyzing experimental data in the context of the chosen model.
In this work, we present the first application of the sparse identification of non-linear dynamics (SINDy) algorithm to a real biological system in order discover cell-cell interaction dynamics in in vitro experimental data, using chimeric antigen receptor (CAR) T-cells and patient-derived glioblastoma cells. By combining the techniques of latent variable analysis and SINDy, we infer key aspects of the interaction dynamics of CAR T-cell populations and cancer.
Importantly, we show how the model terms can be interpreted biologically in relation to different CAR T-cell functional responses, single or double CAR T-cell-cancer cell binding models, and density-dependent growth dynamics in either of the CAR T-cell or cancer cell populations.
We show how this data-driven model-discovery based approach provides unique insight into CAR T-cell dynamics when compared to an established model-first approach. These results demonstrate the potential for SINDy to improve the implementation and efficacy of CAR T-cell therapy in the clinic through an improved understanding of CAR T-cell dynamics.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。